This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Constellation Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Alamelu Banda: Innovator in Pharmaceutical Chemistry
Introduction
Alamelu Banda is a notable inventor based in Winchester, MA (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds that have therapeutic potential.
Latest Patents
Alamelu Banda holds a patent for a compound titled "Crystalline forms of 7-chloro-2-(4-3-methoxyazetidin-1-yl)cyclohexyl)-2,4-dimethyl-N-((6-methyl-4-(methylthio)-2-oxo-1,2-dihydropyridin-3-yl)methyl)benzo[d][1,3]dioxole-5-carboxamide." This patent describes a crystalline Form 1 of the compound, which is useful as a modulator of histone methyl modifying enzymes. The disclosure also includes pharmaceutically acceptable compositions comprising the crystalline form and methods for using these compositions in the treatment of various disorders. Alamelu Banda has 1 patent to her name.
Career Highlights
Alamelu Banda is currently associated with Constellation Pharmaceuticals, Inc., where she continues to advance her research in pharmaceutical innovations. Her work focuses on developing compounds that can effectively target specific biological pathways.
Collaborations
Alamelu has collaborated with Victor S Gehling, contributing to the advancement of their shared research goals.
Conclusion
Alamelu Banda is a pioneering inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of various disorders. Her innovative contributions and ongoing research efforts continue to shape the future of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
